Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Blaive

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study from the Groupe Franais Pneumo-CancérologieJ P Kleisbauer, D Vesco, J Orehek, et al.
Presse Medicale (Paris, France : 1983)|October 29, 1983
[Intralymphatic injections of tumor cells in pulmonary epidermoid cancers]C M Lalanne, G Juillard, J Gioanni, et al.
Revue Des Maladies Respiratoires|January 1, 1985
[Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment]J C Ansquer, A Bertrand, B Blaive, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study from the Groupe Franais Pneumo-CancérologieJ P Kleisbauer, D Vesco, J Orehek, et al.
Presse Medicale (Paris, France : 1983)|October 29, 1983
[Intralymphatic injections of tumor cells in pulmonary epidermoid cancers]C M Lalanne, G Juillard, J Gioanni, et al.
Revue Des Maladies Respiratoires|January 1, 1985
[Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment]J C Ansquer, A Bertrand, B Blaive, et al.
Pageof 8